Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


NIOSH Radiation Dose Reconstruction Program


Section Navigation
			
			CDC Home








alert icon
            Cybersecurity Modernization Initiative
                We are taking steps to continue to modernize and secure our data, applications, and systems. We completed the first phase and restored many of the functions put on pause in May 2021. Now that the first phase is complete, work will resume at a slower pace but will speed up as new systems and applications are brought online. For more information and updates, please visit our Cybersecurity Modernization Initiative web page.
								

				Harshaw Chemical Company						Print
																Related Pages
										On This Page
			Special Exposure CohortTechnical DocumentsProgram Evaluation Plans and Reports (PEPs and PERs)Public CommentsDocument Archive
		
(Site Profile/Docket Number 087)
Location: Cleveland, Ohio
Also Known As: Harshaw Filtrol Partners, Uranium Refinery
Special Exposure Cohort Petition Information
The Special Exposure Cohort (SEC) is a unique category of employees established by The Act (42 CFR Part 83). Claims compensated under the SEC do not have to go through the dose reconstruction process. To qualify for compensation under the SEC, a covered employee must meet specific requirements (e.g., must have at least one of 22 “specified cancers,” and have worked for a specified time period at one of the SEC sites). Classes of employees and work sites can be considered for addition to the SEC through a NIOSH petition process. More information about the Special Exposure Cohort can be found on our Frequently Asked Questions page.
Open/Active SEC Petitions
To date, there are no open/active SEC petitions from Harshaw Chemical Company.
Class(es) Added to the SEC
Atomic Weapons employees who were monitored or should have been monitored while working at the Harshaw Harvard-Denison Plant located at 1000 Harvard Avenue in Cleveland, Ohio, from August 14, 1942, through November 30, 1949, and who were employed for a number of work days aggregating at least 250 work days or in combination with work days within the parameters established for one or more other classes of employees in the Special Exposure Cohort.
**Note:** This class was established from Petition 66Petitions Qualified for Evaluation
Below is a list of the petitions that qualified for evaluation. Select a petition on the list to view the table for that particular petition.
Petition 66 (Aug 14, 1942 to Nov 30, 1949)
	Petition 66
Steps in Petition Process:
Petition Details:Date Received
July 24, 2006Date Qualified for Evaluation
July 25, 2006Summary of Information in Petition
**Location:** Cleveland, Ohio
**Job Titles and/or Job Duties:** All workers at Harshaw Chemical Company plant and the laboratories of the separate facility located at 1945 East 97th Street
**Period of Employment:** January 1, 1942 through November 30, 1949
**Note:** The information above is what qualified for evaluation. During our evaluation of whether dose reconstructions can adequately be completed for the above job titles and period of employment, information may cause NIOSH to change some the dates or job titles/duties. Therefore, as this petition proceeds through the SEC petition process and if an SEC class is proposed, the proposed class may not exactly match the above information.Copy of the Petition Received
July 24, 2006 [757 KB (2 pages)](January 1, 1942 through November 30, 1949)Federal Register Notice Announcing that a Harshaw Chemical Company SEC Petition has met the Minimum Qualifications for Review and Evaluation
August 4, 2006 [42 KB (1 page)](January 1, 1942 through November 30, 1949)SEC Petition Evaluation Report
December 5, 2006 [148 KB (24 pages)](August 14, 1942 through November 30, 1949)Evaluation Report Sent to the Advisory Board
December 5, 2006(August 14, 1942 through November 30, 1949)Petition Discussed by the Advisory Board
The petition was discussed by the Advisory Board during its December 11-13, 2006, meeting in Naperville, Illinois.
**Note:** Agendas and transcripts for Board meetings will be posted on the Advisory Board and Public Meetings page as soon as they become available.Advisory Board Recommendation on SEC Petition
January 2, 2007 [396 KB (2 pages)](August 14, 1942 through November 30, 1949)HHS Letters to Congress Regarding the SEC Petition
February 1, 2007 [265 KB (6 pages)](August 14, 1942 through November 30, 1949)HHS Designation/Determination of Additional Members to the SEC
**Designation:**
February 1, 2007 [177 KB (4 pages)](August 14, 1942 through November 30, 1949)
**Note:** A “designation” means that HHS is recommending a class be added to the SEC. A “determination” means that HHS is recommending a class **not** be added to the SEC.Federal Register Notice: Designation/Determination of a Class of Employees for Addition to the Special Exposure Cohort
**Designation:**
March 1, 2007 [46 KB (1 page)](August 14, 1942 through November 30, 1949)
**Note:** A “designation” will be published if there is a recommendation to add a class to the SEC. A “determination” will be published if there is a recommendation **not** to add a class to the SEC.Effective Date for the SEC Class
March 3, 2007(August 14, 1942 through November 30, 1949)
**Note:** This only applies if the class is added to the SEC.Federal Register Notice: Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort
March 16, 2007 [96 KB (2 pages)](August 14, 1942 through November 30, 1949)
**Note:** This only applies if the class is added to the SEC.Letter to DOL Regarding the Addition of a New Class of Employees to the SEC
March 8, 2007 [20 KB (2 pages)](August 14, 1942 through November 30, 1949)
**Note:** This only applies if the class is added to the SEC.
Technical Documents
If the energy employee’s personal radiation information is incomplete, NIOSH will use other sources to estimate the radiation dose. This may involve using technical documents called Site Profiles, Technical Basis Documents, and Technical Information Bulletins.
Site Profile
An Exposure Matrix for the Harshaw Chemical Company, Cleveland, Ohio [1.4 MB (111 pages)] Revised June 2, 2009
**Revision Includes:** Tables 5-6 and A-7 were modified and Figures A-3, A-4, A-5, A-8, A-9, and A-10 were replaced to correct an error in Rev 00. Figures A-1, A-2, A-6, and A-7 replaced to match the formatting of the modified figures. The footnote to Table B-25 was modified to clarify that the intakes listed are in terms of total alpha. The text in Section 5.9.5 was also modified to reflect this clarification. No comments were received as a result of formal internal review. Incorporates formal NIOSH review comments.Program Evaluation Plans (PEPs) and Program Evaluation Reports (PERs)
NIOSH is committed to applying the best available science in dose reconstructions. In keeping with this commitment, completed cases with probabilities of causation less than 50% are reviewed as relevant new information becomes available. The results of these reviews are described in a Program Evaluation Report (PER). The PER details the effect, if any, of the new information on the completed dose reconstruction. If it appears that the new information may result in an increase in dose for a completed dose reconstruction with a probability of causation of less than 50%, NIOSH is committed to working with the Department of Labor to reopen and rework the dose reconstruction, as appropriate. A Program Evaluation Plan (PEP) describes plans for evaluating specific program details or issues.
DCAS-PER-034 Rev-0: Harshaw Chemical Company TBD Revision [15 KB (2 pages)] December 9, 2011
**About this Document:** Determines affect of revising the Harshaw TBD on previously completed claims.
**Approved:** December 9, 2011
**Summary:** Several editorial changes and clarifications were included in the revision however these changes do not affect the estimated dose. Some changes may have decreased the dose but the only significant increase in the dose estimate is caused by an increase in the estimated intake rate for type S uranium from 12/1/1949 to 12/31/1953. The values are listed in Table 5-6 of both revisions.Public Comments on Harshaw Chemical Company Documents
How to Submit Comments
Comments on Harshaw Chemical Company Documents can be submitted to the NIOSH Docket Officer electronically by email at nioshdocket@cdc.gov or printed comments can be mailed to:
NIOSH Docket Office Robert A. Taft Laboratories, MS-C34 1090 Tusculum Avenue Cincinnati, OH 45226 Please include the Site Profile/Docket Number (087) on all comments.
Comments Received
At this time, no comments have been submitted.
Document Archive for Harshaw Chemical Company
An Exposure Matrix for the Harshaw Chemical Company, Cleveland, Ohio [1.4 MB (114 pages)] Approved August 17, 2007
							
					
							Last Reviewed:  June 30, 2022						Source: 	National Institute for Occupational Safety and Health
					Facebook
        Twitter
        LinkedIn
        Syndicate homeRadiation Dose ReconstructionAbout DCASThe Act/EEOICPADose Reconstruction (DR)plus iconDataplus iconSourcesFormats & TypesSensitive DataWork History                            Phone CallData Search and Capture EffortsMethodsProductionTechnical Documents Used in Dose ReconstructionsProgram Evaluation Reports and PlansQuality Assurance and Quality ControlSupport ContractorSoftware (IMBA)RECA ClaimsProbability of Causationplus iconCalculating PCNews & UpdatesNIOSH-IREP SoftwareSpecial Exposure Cohortplus iconSubmit a PetitionCheck Petition Statusplus iconSEC Status TableGet HelpResidual ContaminationAdvisory Boardplus iconPublic MeetingsSubcommittee and Work GroupsSEC Petition RecommendationsTechnical Support for the Review of NIOSH Dose Reconstruction ProgramReports from the Advisory Board's Technical Support ContractorTechnical Review Summaries from the Technical Support ContractorProceduresCorrespondenceWork Site InformationPublications & ProductsProgram ReviewsReports to CongressPolicies, Procedures, and GuidelinesNIOSH Public DocketRelated Program LinksContact UsHELPplus iconHelp A – ZAccessibilityAcronymsFrequently Asked Questions (FAQs)plus iconThe ActCase ConcernsClaimant CorrespondenceConflict or BiasDose ReconstructionFreedom of Information Act (FOIA)National Defense Authorization ActNIOSH-IREPProbability of CausationResidual Contamination ReportResponsibilities under Subtitle B of EEOICPA (The Act)Special Exposure CohortTechnical DocumentsWork History Phone CallGlossary Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue